NCT03912571View on ClinicalTrials.gov

Sleep Disordered Breathing and Alzheimer's Disease Biomarkers in Normal Aging and Mild Cognitive Impairment

CompletedOBSERVATIONAL
Enrollment

28

Participants

Timeline

Start Date

November 13, 2011

Primary Completion Date

September 30, 2019

Study Completion Date

September 30, 2019

Conditions
Sleep Disorder
Interventions
DIAGNOSTIC_TEST

Structural 3T MRI

measures of global and hippocampal atrophy)

DIAGNOSTIC_TEST

MRI Based Perfusion Imaging

brain blood flow

DIAGNOSTIC_TEST

VR-CO2 MRI Scans

reduced vaso reactivity to carbon dioxide

Trial Locations (1)

10016

NYU Langone Medical Center, New York

All Listed Sponsors
lead

NYU Langone Health

OTHER

NCT03912571 - Sleep Disordered Breathing and Alzheimer's Disease Biomarkers in Normal Aging and Mild Cognitive Impairment | Biotech Hunter | Biotech Hunter